Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 4/20 | 0.55 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.55 |
| ▸ | SIGMAR1 | Q99720 | 15/20 | 0.48 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.46 |
| ▸ | F10 | P00742 | 3/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6602820 | 0.92 | ITGB3 (0.59) | ITGB3ITGA2BSIGMAR1GRM2PRSS1 | |
| SCHEMBL6535864 | 0.91 | ITGB3 (0.53) | ITGB3ITGA2BSIGMAR1GRM2F10 | |
| SCHEMBL7309835 | 0.91 | ITGB3 (0.49) | ITGB3ITGA2BSIGMAR1GRM2F10 | |
| Gantofiban SCHEMBL6600995 | 0.89 | ITGB3 (0.70) | ITGB3ITGA2BSIGMAR1GRM2F10 | |
| Gantofiban SCHEMBL6600994 | 0.89 | ITGB3 (0.70) | ITGB3ITGA2BSIGMAR1GRM2F10 | |
| Gantofiban SCHEMBL6602032 | 0.89 | ITGB3 (0.70) | ITGB3ITGA2BSIGMAR1GRM2F10 | |
| SCHEMBL6605957 | 0.89 | ITGB3 (0.56) | ITGB3ITGA2BSIGMAR1GRM2 | |
| SCHEMBL6600606 | 0.88 | ITGB3 (0.55) | ITGB3ITGA2BSIGMAR1GRM2 | |
| SCHEMBL7309830 | 0.88 | ITGB3 (0.51) | ITGB3ITGA2BSIGMAR1GRM2F10 | |
| SCHEMBL7304344 | 0.88 | ITGB3 (0.48) | ITGB3ITGA2BSIGMAR1GRM2F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6455529-B1 | OXAZOLIDIN-2-ONE DERIVATIVES; ANTICOAGULANTS; ANTIMETASTASIS, ANTICARCINOGENIC, ANTIISCHEMIC, AND ANTIINFLAMMATORY AGENTS; OSTEOPOROSIS, ARTERIOSCLEROSIS | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2002-09-24 | — | — | US | disclosed |
| EP-0741133-A2 | Adhesion receptor antagonists | MERCK PATENT GmbH (DE) | 1996-11-06 | — | — | EP | disclosed |